Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas R Lane

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Antiviral Research|July 20, 2020
Pyronaridine tetraphosphate efficacy against Ebola virus infection in guinea pigThomas R Lane, Christopher Massey, Jason E Comer, et al.
ACS Infectious Diseases|April 30, 2025
Cryo-EM Structure of HIV-1 Reverse Transcriptase with <i>N</i>-Phenyl-1-(phenylsulfonyl)-1<i>H</i>-1,2,4-triazol-3-amine: A New HIV-1 Non-nucleoside InhibitorMegan A Young, Thomas R Lane, Renuka Raman, et al.
ACS Infectious Diseases|January 12, 2021
A Machine Learning Strategy for Drug Discovery Identifies Anti-Schistosomal Small MoleculesKimberley M Zorn, Shengxi Sun, Cecelia L McConnon, et al.
Tuberculosis (Edinburgh, Scotland)|March 3, 2024
Computational drug repositioning identifies niclosamide and tribromsalan as inhibitors of Mycobacterium tuberculosis and Mycobacterium abscessusJeremy J Yang, Aaron Goff, David J Wild, et al.
Journal of Chemical Information and Modeling|August 13, 2021
Machine Learning Models Identify Inhibitors of SARS-CoV-2Victor O Gawriljuk, Phyo Phyo Kyaw Zin, Ana C Puhl, et al.
Antiviral Research|June 16, 2023
Efficacy of an isoxazole-3-carboxamide analog of pleconaril in mouse models of Enterovirus-D68 and Coxsackie B5Thomas R Lane, Jianing Fu, Barbara Sherry, et al.
Journal of Medicinal Chemistry|November 3, 2023
High-Throughput Phenotypic Screening and Machine Learning Methods Enabled the Selection of Broad-Spectrum Low-Toxicity Antitrypanosomatidic AgentsPasquale Linciano, Antonio Quotadamo, Rosaria Luciani, et al.
ACS Infectious Diseases|May 24, 2022
Pyronaridine Protects against SARS-CoV-2 Infection in MouseAna C Puhl, Giovanni F Gomes, Samara Damasceno, et al.
ACS Infectious Diseases|March 20, 2025
<i>Mycobacterium tuberculosis</i> Sulfate Ester Dioxygenase Rv3406 Is Able to Inactivate the RCB18350 CompoundDeborah Recchia, Giovanni Stelitano, Anna Egorova, et al.
Tuberculosis (Edinburgh, Scotland)|September 13, 2018
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymeraseGiorgia Mori, Beatrice Silvia Orena, Clara Franch, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Antiviral Research|July 20, 2020
Pyronaridine tetraphosphate efficacy against Ebola virus infection in guinea pigThomas R Lane, Christopher Massey, Jason E Comer, et al.
ACS Infectious Diseases|April 30, 2025
Cryo-EM Structure of HIV-1 Reverse Transcriptase with <i>N</i>-Phenyl-1-(phenylsulfonyl)-1<i>H</i>-1,2,4-triazol-3-amine: A New HIV-1 Non-nucleoside InhibitorMegan A Young, Thomas R Lane, Renuka Raman, et al.
ACS Infectious Diseases|January 12, 2021
A Machine Learning Strategy for Drug Discovery Identifies Anti-Schistosomal Small MoleculesKimberley M Zorn, Shengxi Sun, Cecelia L McConnon, et al.
Tuberculosis (Edinburgh, Scotland)|March 3, 2024
Computational drug repositioning identifies niclosamide and tribromsalan as inhibitors of Mycobacterium tuberculosis and Mycobacterium abscessusJeremy J Yang, Aaron Goff, David J Wild, et al.
Journal of Chemical Information and Modeling|August 13, 2021
Machine Learning Models Identify Inhibitors of SARS-CoV-2Victor O Gawriljuk, Phyo Phyo Kyaw Zin, Ana C Puhl, et al.
Antiviral Research|June 16, 2023
Efficacy of an isoxazole-3-carboxamide analog of pleconaril in mouse models of Enterovirus-D68 and Coxsackie B5Thomas R Lane, Jianing Fu, Barbara Sherry, et al.
Journal of Medicinal Chemistry|November 3, 2023
High-Throughput Phenotypic Screening and Machine Learning Methods Enabled the Selection of Broad-Spectrum Low-Toxicity Antitrypanosomatidic AgentsPasquale Linciano, Antonio Quotadamo, Rosaria Luciani, et al.
ACS Infectious Diseases|May 24, 2022
Pyronaridine Protects against SARS-CoV-2 Infection in MouseAna C Puhl, Giovanni F Gomes, Samara Damasceno, et al.
ACS Infectious Diseases|March 20, 2025
<i>Mycobacterium tuberculosis</i> Sulfate Ester Dioxygenase Rv3406 Is Able to Inactivate the RCB18350 CompoundDeborah Recchia, Giovanni Stelitano, Anna Egorova, et al.
Tuberculosis (Edinburgh, Scotland)|September 13, 2018
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymeraseGiorgia Mori, Beatrice Silvia Orena, Clara Franch, et al.
Pageof 8